OncoSec Medical Inc (ONCSQ)

[chickpea598]

Merck is totally focused on Keytruda and exploiting every possibility with it. They lucked into it through a merger and only started focusing in on it after Bristol Myers had success with Opdivo. Better late than never. Now Merck has leapfrogged over Bristol and imagine the possibilities in Lung Cancer if Oncosec gets an approval for the PISCES trial in the non-responder population.....you can bet Merck will exploit the shit out of this in Lung Cancer and TNBC, Merkel Cell, Head and Neck.....all indications that are Keytruda approved or soon to be approved. The sky is the limit for Oncosec share price.... we just need positive data next year in PISCES trial and we are golden here.